跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TISSEEL KIT VH 2.0 - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TISSEEL KIT VH 2.0
Authorized
STANDARD
TISSEEL KIT VH 2.0
Baxter AG
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e02c17a1770f4dff
Company
Baxter AG
Type
Standard
Approval Details
Approval Id
e02c17a1770f4dff
Drug Approval Canada Name
TISSEEL KIT VH 2.0
Product Name
TISSEEL KIT VH 2.0
Status
Cancelled Post Market
Status Date
2014-06-10
Original Market Date
1998-10-13
Din
02233274
Drug Class
Human
Dosage Form
Liquid , Kit , Powder For Solution
Route Of Administration
Topical
Schedule
Schedule D , Prescription
Ahfs
20:28.16
Atc Original
B02BD20 COMBINATIONS
Atc Name
b 02 bd 20
Aig Number
0936991008
Company Name
Baxter AG
Company Address
Industriestrasse 67, Vienna, Saone Et Loire, Austria, 1220
Company Detail Path
/organization/baxter-ag
Company Information
Pharmaceutical Company Name
Baxter AG
Country Name
Switzerland
Province Name
Zürich
City Name
glattpark (opfikon),zürich,country_ch
Address
Thurgauerstrasse 130
Website
http://www.baxter.ch
Active Ingredients
APROTININ (BOVINE)
6000 KIU / 2 ML
CALCIUM CHLORIDE
80 MCMOL / 2 ML
FIBRINOGEN (HUMAN)
220 MG / 2 ML
FACTOR XIII
100 UNIT / 2 ML
PLASMINOGEN
240 MCG / 2 ML
THROMBIN (HUMAN)
8 UNIT / 2 ML
TOTAL PROTEIN
260 MG / 2 ML
THROMBIN (HUMAN)
1000 UNIT / 2 ML
PLASMAFIBRONECTIN (CIG)
18 MG / 2 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e02c17a1770f4dff
Type
Standard
Back to Health Canada Approvals